Cansortium Investor Relations Material

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges and edibles. The company has a network of 28 dispensaries in Florida that provide their services under their own brand name Cansortium Holdings Acquisition Corporation.